AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TENOLAM TABLET, COATED; ORAL | 2013/7.13/4794 | HETERO LABS LTD | active | 22 Jun 2030 |
| LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2020/7.13/6067 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 18 Jul 2029 |
| LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2022/7.13/6361 | LUPIN LIMITED | active | 31 Dec 2027 |
| LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE TABLET, COATED; ORAL | 2020/7.13/6005 | MICRO LABS LTD | active | 31 Dec 2027 |
| RICOVIR-L TABLET; ORAL | 2010/7.13/4653 | MYLAN LABORATORIES LIMITED | active | 31 Dec 2027 |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.